TY  - CONF

T1  - Meta-analysis of effects of zoledronic acid (ZOL) on survival in metastatic bone disease (MBD): Survival in patients with high bone turnover

JO  - JOURNAL OF CLINICAL ONCOLOGY

PY  - 2008/05/20

AU  - Cook RJ

AU  - Hirsh V

AU  - Major PP

AU  - Saad F

AU  - Dias R

AU  - Lipton A

AU  - Coleman RE

ED  - 

DO  - DOI: 10.1200/jco.2008.26.15_suppl.20562

VL  - 26

IS  - 15

Y2  - 2025/10/10

ER  -